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PROBLEM: The immunologic mechanisms of pregnancy loss in habitual aborters with 
antiphospholipid and antinuclear antibodies have not been fully clarified. The possible 
association of antineutrophil cytoplasmic antibodies (ANCAs) with recurrent miscar- 
riage was examined. 
METHOD OF STUDY: In a prospective, controlled trial of 59 women with recurrent 
abortion, the prevalence of pANCA (antimyeloperoxidase), cANCA (antiproteinase- 
3). and immunoserologic abnormalities of systemic lupus erythematosus (SLE)-anti- 
double-stranded DNA, anti-SSA, anti-SSB, anti-UI RNP, anti-Sm, anticardiolipin and 
antinuclear antibodies, LE-cell, lupus anticoagulant, and complement-3-were investi- 
gated. 
RESULTS: pANCA occurred in 2, and cANCA in 6 of 59 case patients, but neither 
was observed in the controls ( P  = 0.09 for cANCA). cANCA levels were significantly 
higher in patients than in controls ( P  = 0.028). Six recurrent aborters were identified as 
having a group of immunoserologic abnormalities characteristic of SLE. 
CONCLUSIONS: Immunologic mechanisms detectable in SLE may operate in a 
subgroup of habitual aborters with suspected immunologic cause. ANCAs occur more 
frequently in patients with recurrent miscarriage than in controls. 
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Antiphospholipid antibodies have been reported to be associated with idio- 
pathic habitual abortion,'-' and recent investigations have also demonstrated 
their value for the prediction of an adverse outcome in subsequent preg- 
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nancy.'.' A relationship has also been revealed be- 
tween the presence of antinuclear antibodies and re- 
current miscarriage, although data are far less 
consistent.'- "I Thyroid and antimitochondrial anti- 
bodies have also been investigated in connection 
with recurrent miscarriage.' The pathomechanism 
by which these antibodies may cause fetal death is 
by no means clear. I t  is believed by some that the 
autoantibodies may be only an epiphenomenon 
reflecting a separate underlying immunologic mecha- 
nism." 
In systemic lupus erythematosus (SLE), an in- 
creased rate of spontaneous abortions may be ob- 
served even before the onset of the classical 
symptoms of the disease.I3 Therefore, we have 
started a study of women with idiopathic recurrent 
spontaneous abortion with the aim of investigating a 
wide spectrum of immunoserologic markers occur- 
ring in patients with SLE, and intend to follow up 
these patients for a long period. We wish to answer 
the question of whether the underlying immunologic 
disorder may be regarded as a preclinical SLE or a 
related, nonclassified systemic autoimmune disease. 
Systemic vasculitides constitute another group of 
systemic autoimmune diseases. Antineutrophil cyto- 
plasmic antibodies (ANCAs) are useful tools in the 
diagnosis of certain types of systemic vasculitides, 
especially Wegener's granulomatosis, microscopic 
polyangiitis, and Churg-Strauss syndrome, and they 
occur in other autoimmune diseases too, such as 
SLE.''.'-' As far as we are aware. they have not 
been investigated previously in the context of habit- 
ual abortion. We therefore examined their preva- 
lence among our study patients. 
MATERIALS AND METHODS 
The study involved 59 women with a history of at 
least two consecutive spontaneous abortions in preg- 
nancies from the same partner. Their average age was 
30.47 years (range 19-47 years). Genetic, endocrine. 
anatomical, infectious, and internal medical causes of 
habitual abortion were excluded. None of the patients 
had a clinically obvious systemic autoimmune disease 
or a chronic medical illness. Eighteen of the 59 women 
had a prior pregnancy ending in a live delivery. Seven 
patients had pregnancies with two partners. Two of 
them had at least two consecutive fetal losses with 
both partners. One patient had two miscarriages with 
the first partner and one further spontaneous abortion 
with the second. The remaining four women all had 
their miscarriages with the second partner, and nor- 
mal pregnancies with the first. The patients were not 
receiving any regular medication at the time of the 
examinations. 
The control group comprised 25 healthy women 
with no history of fetal loss. All of them had at least 
two successful pregnancies before the blood sampling. 
Their average age was 30.08 years (range 21-37 
years). 
A comparison of the obstetric data on the women 
in the two groups is presented in Table I .  Spontaneous 
abortion was defined as pregnancy loss before the 
twenty-eighth completed week of gestation. Two in- 
trauterine deaths occurred in two patients in the 
thirty-fifth or thirty-eighth week of gestation. The 
term fetal loss is therefore used to cover both sponta- 
neous abortions and late intrauterine deaths. Three 
infants died after live births in the twenty-fifth, 
twenty-sixth or twenty-seventh week of gestation, and 
TABLE I. Age and Obstetric History of Habitual Abortion Patients and Normal Controlsa 
Habitual abortion 
(n = 59) 
Control (n = 25) 
Age (years, mean k SD, range) 30.47 k 5.68, 19-47 30.08 k 5.33, 
21 -37 
No. of previous pregnancies (mean f SD, range)* 2.44 i 0.71, 
No. of previous live deliveries (mean k SD, range) 0.41 & 0.62, 0-2 2.16 0.37, 
3.51 & 1.56, 2-9 
2-5 
2-5 
0 
0.20 k 0.41, 
0-1 
No. of previous fetal losses (overall) (mean i- SD, range) 2.76 1.21, 2-8 0 
No. of previous second-trimester spontaneous abortions (mean f SD, 0.63 k 0.71, 0-4 
0.31 k 0.59, 0-2 
range) 
No. of previous induced abortions (mean f SD, range) 
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one infant born at term died 1 day after delivery. 
Induced abortions were performed before the twelfth 
week of gestation for reasons other than medical ones. 
Blood was taken in the nonpregnant state from per- 
sons in both groups. 
Laboratory techniques included indirect immu- 
nofluorescence for the detection of antinuclear anti- 
bodies; rotatory method utilizing heparin and glass 
beads for lupus erythematosus (LE) cell investigation; 
rocket immunoelectrophoresis for the measurement of 
complement-3 levels; complement consumption test to 
assess circulating immunocomplexes (CICs): determi- 
nation of activated partial thromboplastin time for the 
detection of lupus anticoagulant (LAC); and enzyme- 
linked immunosorbent assays (ELISAs) to detect anti- 
cardiolipin (aCL) immunoglobulin G (IgG) (Shield 
Diagnostics. Dundee, UK). anti-double-stranded 
DNA (anti-dsDNA), anti-SSA, anti-SSB. anti-Sm, 
and anti-U 1 RNP (Epignost, Leonding Linz. Austria) 
autoantibodies. Evaluation of cANCA was performed 
with an ELISA using proteinase-3 (PR-3) as antigen. 
while the presence of pANCA was assessed with an 
anti-myeloperoxidase (anti-MPO) ELISA (Shield Di- 
agnostics, Dundee, UK). Precoated ELISA kits were 
used in accordance with the manufacturer's instruc- 
tions. Cases were considered to involve LE-cell posi- 
tivity when typical LE cells or the characteristic 
round, homogenous hematoxylin bodies were ob- 
served. This examination was not performed in four 
of the study patients. Similarly, LAC was not exam- 
ined in seven of the study patients. 
The Student's r-test was used in comparisons of age 
and of the numbers of previous pregnancies, deliver- 
ies, and induced abortions between the study and 
control groups. The x2  test or Fisher's exact test were 
applied in comparisons of the frequencies of various 
immunologic variables between the two groups. For 
the comparison of the cANCA levels, the Mann-Whit- 
ney U-test was applied. 
RESULTS 
The most common serologic markers used in  the 
diagnosis and follow-up of SLE were examined in 
both groups. The frequencies of anti-dsDNA. anti- 
SSA. anti-SSB. anti-Sin. anti-U 1 RNP. anti-cardiolipin 
IgG autoantibodies; the lupus anticoagulant; LE cell: 
antinuclear antibodies: and decreased complement-3 
levels in women suffering habitual abortion and i n  
healthy control women are presented in  Table 11. For 
aCL. the prevalences of markedly elevated levels 
(more than 2.5 times higher than the upper limit of 
the normal range) are also presented. Although aCL 
and LAC occurred more frequently in habitual 
TABLE II. Frequencies of Immunologic Changes in 
Habitual Abortion Patients and in Normal Controls" 
Habitual Control (%) 
abortion (%) 
Antinuclear antibodies 2 59 (3.39) 2 25 (8.0) 
Anti-dsDNA 2 59 (3.39) 2 25 (8.0) 
Anti-SSA 1 59 (1.69) 0 25 
Anti-SSB 1 59 (1.69) 0 25 
Anti-Sm 0 59 0 25 
Anti-U1 RNP 0 59 0 25 
Anti-cardiolipin 17 59 (28.81) 4 25 (16.0) 
Anti-cardiolipin moderate 5 59 (8.47) 0 25 
Lupus anticoagulant 6 52 (11.54) 1 22 (4.54) 
Lupus erythematosus 6 55 (10.91) 1 25 (4.0) 
Decreased 12 59 (20.34) 4 25 (16.0) 
pANCA 2 59 (3.39) 0 25 
cANCA* 6 59 (10.17) 0 25 
to high positive 
cell 
complement-3 
aborters. and markedly elevated levels of aCL were 
found only in the study group (in five patients). no 
significant differences were observed i n  the preva- 
lences of the examined serologic variables between the 
two groups. 
pANCA was found in 2 59 examined patients but i n  
none of the controls, while cANCA was found in 6 59 
examined patients but none of the controls. This latter 
difference approaches, but does not quite reach, the 
level of statistical significance ( P  = 0.09). However, 
when the levels of cANCA were compared in the two 
groups, statistically higher values were revealed in the 
habitual abortion patients than in the healthy persons 
( P  = 0.028). The titers of both ANCA types were in 
the low and the moderately high range (maximum 2.5 
times higher than the upper limit of the normal range) 
in the patient group. The distribution of the autoanti- 
body levels i n  the study group is to be seen in  Fig. I .  
A comparison of the cANCA levels i n  the habitual 
abortion patients and the controls is represented i n  
Table 111 and Fig. 2. A similar comparison did not 
receal a difference in the pANCA titers (data not 
shown). The serologic characteristics and obstetric 
histories of the eight patients with either pANCA or 
cANCA positivity are summarized in  Table IV. The 
age and the obstetric history data do not differ signifi- 
cantly from those for the overall gro~ip of habitual 
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aborters. In half of these eight patients, no other 
immunoserologic abnormality was revealed, while the 
other four patients were positive for aCL. Statistical 
analysis did not confirm that ANCA positivity is more 
likely in patients with aCL. 
Among the 59 patients with recurrent abortion, 28 
proved positive for at least one of the examined 
laboratory variables. The majority exhibited only one 
positive value, most often an increased aCL antibody 
titer. However, six patients displayed a wide spectrum 
of laboratory abnormalities. The findings on these six 
patients are presented in Table V. None of them were 
positive for either pANCA or cANCA. The reproduc- 
tive performances of these 6 women were as follows: 
27 pregnancies (4.5 person), three live deliveries (0.5 
person), 2 1 spontaneous abortions (3.5 person), and 
three induced abortions (0.5 person). No fetal loss 
occurred after the twenty-eighth gestational week. 
These data do not differ significantly from those for 
the overall group of habitual aborters. I t  should be 
noted that patient 6 experienced eight consecutive 
spontaneous abortions after a normal delivery, six 
from the first and two from a second partner. Two 
other women had recurrent abortions with two male 
partners; one of these women had a decreased comple- 
ment-3 level, while the other had no immunoserologic 
abnormality. 
A 
A 
A 
A A  A 
DISCUSSION 
It is widely accepted that antiphospholipid antibodies 
(including aCL and LAC), and possibly antinuclear 
antibodies. are in some way associated with recurrent 
abortion. The underlying immunologic mechanism 
has been the subject of numerous examinations in- 
volving different approaches.“ ’” I n  the present study 
we examined a number of immunologic abnormalities 
on which the evaluation of patients with SLE is based. 
Although the prevalence of aCL and LAC was 
higher in  patients with recurrent abortion than in the 
controls. and high titers of aCL were detected only in 
the study group. no difference proved significant. 
12,oo 
10,oo 
0 8,OO 
c $  6,OO 
5 4,OO 
2,oo 
0,oo 
a - 
82.  .- - 
. 
A 
Antinuclear antibodies were detected in small num- 
bers of patients in both groups, while LE cell and 
decreased complement-3 levels were not infrequent in 
patients with recurrent miscarriage, although again 
without statistical significance. In 31 of the patients, 
no immunologic positivity was found at all, whereas 6 
otherwise asymptomatic habitual aborters could be 
identified in whom an association of multiple im- 
munologic abnormalities was revealed. The presence 
of this spectrum of autoimmune abnormalities, de- 
tectable at the same time, is very uncommon in other- 
wise asymptomatic persons. This laboratory 
constellation warrants further investigations; in per- 
sons with some clinical symptoms it would be highly 
suggestive of SLE. 
The question of whether recurrent miscarriage may 
be the first clinical sign of SLE has been addressed 
previously,8 and it was concluded that the answer was 
negative. However, in that study. fewer immunologic 
markers were investigated, and the follow-up popula- 
tion (patients with antinuclear antibody positivity) 
was somewhat different from the present one. On the 
other hand, after the detection of anti-dsDNA in 
otherwise healthy individuals, 85%) of them developed 
clinically overt SLE within a few years.”’ In another 
study, in a high proportion of anti-SSA or anti-SSB 
positive mothers of children with isolated congenital 
heart block, symptoms of primary Sjogren’s syndrome 
developed at varying times after delivery.” Therefore, 
we feel that it is worthwhile to follow up these pa- 
tients, especially those with multiple autoimmune lab- 
oratory abnormalities, with special attention to the 
development of signs and symptoms of SLE or of 
other systemic autoimmune diseases. The question we 
wish to answer is whether immunologic processes 
suspected of being involved in the pathogenesis of 
SLE may be underlying factors implicated in the 
elicitation of an adverse pregnancy outcome in a 
specific subgroup of patients with habitual abortion. 
The further investigation of specific T-cell abnormali- 
ties is essential in this regard.”-” 
Systemic vasculitides constitute a heterogenous fam- 
ily of systemic autoimmune diseases. ANCA is a 
1,oo 
0,oo 
CANCA 
Fi,?. I .  Distribution of antimyeloper- 
oxidase (pANCA) and antiproteinase-3 
(cANCA) antibodies i n  patients with 
recurrent abortion. Valties below the 
lines are negatibe. 
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TABLE 111. Comparison of CANCA Levels in Patients with Recurrent Abortion (n = 59) and in Controls (n = 25) 
Antibody titers (U L) 
Mean SD SE Median Min Max 
Habitual abortion 0.81 1.22 0.1 6 0.40 0.10 6.00 
Control 0.32 0.13 0.03 0.30 0.10 0.60 
useful diagnostic aid in some types of systemic vasculi- 
tides. with pANCA being prevalent in  microscopic 
polyangiitis and Churg- Strauss syndrome, and 
cANCA in  Wegener's granulomatosis. I t  can also 
occasionally be found i n  various autoimmune and 
inflaniinatory diseases. such as SLE. drug-induced 
lupus, inflammatory bowel diseases. idiopathic rapidly 
progressive gloiiierulonephritis. or chronic viral hep- 
atitis. The major antigen in patients with ANCA with 
perinuclear staining (pANCA) is myeloperoxidase. 
Lvhile in  those with diffuse cytoplasmic staining 
(cANCA) it is proteinase-3. We detected ANCA in 
eight patients with recurrent miscarriage (pANCA in 2 
and cANCA i n  6) and i n  none of the controls. The 
higher prevalence of cANCA (though the difference is 
of only borderline statistical significance) and the 
higher cANCA levels raise the possibility that this 
autoantibody may i n  some way be associated with 
1 
0.9 
0.8 
0.7 
0,6 - 
Q) > a¶ - 
c 2 0.5 2 2  
2 
.- 
U 
0.4 
0.3 
0.2 
0.1 
0 
Patients 
T 
Controls 
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TABLE IV. Associated Laboratory Abnormalities, Obstetric History, and Age of Antineutrophil Cytoplasmic Antibody 
(ANCA) Positive, Recurrent Abortion Patients" 
Patient 
Fetal loss (trimester) 
Associated laboratory abnormality G P 1st 2nd Age 
1 pANCA 
2 pANCA 
3 cANCA 
4 cANCA 
5 cANCA 
6 cANCA 
7 cANCA 
8 cANCA 
aC L 
aCL 
aCL, CIC 
aCL, CIC 
- 
- 
- 
- 
3 1 2 
3 0 2  
5 2 2  
3 0 3  
8 0 5  
4 0 0  
5 1 3 
2 0 2  
0 33 
0 39 
1 42 
0 28 
1 28 
4 31 
1 26 
0 22 
recurrent abortion. ANCA levels in the study patients 
are lower than those observed in patients with active 
systemic vasculitis. and similar to the levels described 
in studies of patients with SLE. Patients with ANCA 
did not constitute a specific group in respect of age. 
the number of previous pregnancies. or the number or 
duration of gestation of the previous miscarriages as 
compared with the overall group of patients. 
In some inflaniniatory diseases, ANCAs may arise 
as a result of polyclonal immune activation. but in our 
patients no statistically significant association of 
ANCA with any other autoantibodies was revealed. 
In  fact. except for aCL. no other autoantibodies were 
found i n  ANCA positive patients. I t  may be interest- 
ing that none of the six patients with multiple autoim- 
mune laboratory changes had ANCA. and. vice versa. 
ANCA positive patients had relatively few associated 
TABLE V. Laboratory Characteristics of Six Patients 
Selected Because of the Presence of an Association of 
Multiple Autoimmune Serologic Abnormalities 
Patient 
1 LE cell C-31 LAC CIC 
2 Anti-SSA Anti-SSB C-31 CIC 
3 Anti-dsDNA aCL CIC 
laboratory abnormalities. While this may be a coinci- 
dence. i t  may also raise the question of whether the 
reported immunologic findings indicate distinct im- 
munologic pathomechanisms of repeated abortion in 
the patients in these two subgroups. 
One widely-accepted theory16 is that the activation 
of neutrophil granulocytes and endothelial cells by 
certain cytokines is followed by the translocation of 
proteinase-3 to the cell surface, where it binds anti- 
proteinase-3, thereby leading to endothelial injury, 
intravascular lysis of neutrophils, and microvascular 
damage. This process remains to be investigated in the 
endometrium during implantation and placentation. 
The questions of whether the presence of ANCA, 
especially of cANCA, has a specific role in habitual 
abortion. and whether it is of clinical importance in 
reproductive immunology must be answered after the 
follow-up of our patients and further examinations. 
This work was supported by a grant from the Na- 
tional Scientific Research Fund of Hungary (OTKA T 
017 482,. 
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